Goldman Sachs Growth Equity
Goldman Sachs Growth Equity is the growth-stage investment platform of Goldman Sachs Asset Management, deploying $13.2bn across 212 enterprise technology, financial technology, and healthcare technology companies worldwide, supported by 75 operating advisors and the broader Goldman Sachs global franchise.
- Company typePrivate
- Founded2005
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Goldman Sachs Growth Equity does
Goldman Sachs Growth Equity is the dedicated growth-stage investment platform of Goldman Sachs Asset Management, founded in 2005 and headquartered in New York. The firm deploys preferred equity, mezzanine, and minority growth capital into technology-driven companies across three verticals: Enterprise Technology ($6.1bn across 132 companies), Financial Technology ($2.8bn across 42 companies), and Healthcare Technology ($1.5bn across 38 companies), totaling $13.2bn deployed across 212 portfolio companies over a 20-year track record.
The platform's core differentiator is non-capital: portfolio companies receive access to the GS Value Accelerator (75 tenured operating advisors organized into four Centers of Excellence covering Finance & Strategy, Go-to-Market, Product & Technology, and Talent & Organization) and to the broader Goldman Sachs franchise, including ~12,000 investment banking corporate clients, ~3,000 financial institutions, ~16,000 ultra-high-net-worth clients, ~9,000 engineers, and 600+ research analysts. Distribution is relationship-driven — the firm does not market to retail and sources deals through founder relationships, co-investor networks, and GS corporate banking channels.
Returns are generated through equity appreciation realized via IPOs (70+ completed), strategic acquisitions, and secondary transactions. The unit is led by Global Co-Heads Darren Cohen (New York) and Stephanie Hui (Hong Kong), with Johanna Diaz as Global COO, and operates from 10 offices spanning New York, San Francisco, London, Hong Kong, Tokyo, Beijing, Sydney, Mumbai, São Paulo, and Israel. Recent lead investments in Taktile, Hightouch, Aidoc, ORO Labs, Grow Therapy, and Cubby in 2025-2026 indicate an active deployment cadence with growing concentration in AI-enabled enterprise and healthcare technology.
Goldman Sachs Growth Equity firmographics
Firmographics- Name
- Goldman Sachs Growth Equity
- Legal name
- Goldman Sachs Asset Management LP
- Website
- https://growth.gs.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Goldman Sachs Growth Equity is the growth-stage investment platform of Goldman Sachs Asset Management, deploying $13.2bn across 212 enterprise technology, financial technology, and healthcare technology companies worldwide, supported by 75 operating advisors and the broader Goldman Sachs global franchise.
- Ownership category
- akta.pro rank
Goldman Sachs Growth Equity industry classification
Industry- Product category
- Growth Equity Investing
- NAICS
- Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940), Investment Banking and Securities Intermediation (523150)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Technology & Software Growth Equity (FSANACAA)
- akta.pro secondary industries
- Healthcare & Life Sciences Growth Equity (FSANACAB), Financial Services / Fintech Growth Equity (FSANACAE)
Keywords
Where Goldman Sachs Growth Equity is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices9 records
Markets served
Goldman Sachs Growth Equity business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Growth Equity Investment Management: Goldman Sachs Growth Equity generates returns through equity investments in growth-stage technology companies across enterprise technology ($6.1bn deployed, 132 companies), financial technology ($2.8bn deployed, 42 companies), and healthcare technology ($1.5bn deployed, 38 companies) sectors. Returns are realized through IPOs (70+ completed), acquisitions, and secondary transactions.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Goldman Sachs Growth Equity product offering
Product offeringCore offering
Goldman Sachs Growth Equity is the growth equity investment platform within Goldman Sachs Asset Management that invests preferred equity and mezzanine capital in high-growth technology companies across Enterprise Tech, FinTech, and HealthTech. The platform complements its capital with strategic advisory through the Goldman Sachs Value Accelerator and provides portfolio companies access to Goldman Sachs' broader network and resources.
Product overview
Goldman Sachs Growth Equity operates as a growth equity investment platform rather than a software product company. The platform offers growth capital investment, operational support through the GS Value Accelerator (with 75+ operating advisors across Finance & Strategy, Go-to-Market, Product & Technology, and Talent & Organization Centers of Excellence), access to the GS Network (leveraging Goldman Sachs' banking, engineering, and research resources), and membership in a portfolio company community spanning 212 companies across three technology sectors.
Differentiator
Problem solved
Functional benefit
Products and services
- Growth Equity Capital Investments
Quantifiable outcome
- 70+ IPOs completed by portfolio companies
- +4 more outcomes
Companies that use Goldman Sachs Growth Equity
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles1 record
Goldman Sachs Growth Equity technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Goldman Sachs Growth Equity partnerships and signals
Strategic signalScale indicators11 records
Recent moves6 records
Expansion highlights5 records
Goldman Sachs Growth Equity competitors and assessment
Company assessmentBroad incumbents
- Thoma Bravo: Thoma Bravo is a leading software-focused private equity firm. Although more buyout-oriented than GS Growth, it increasingly competes for large, mature enterprise software companies at similar check sizes and valuations.
- Hellman & Friedman: Hellman & Friedman is a large private equity firm with significant technology and financial services investing activity. While broader in mandate than pure growth equity, it competes for many of the same late-stage opportunities.
Direct peers
- Summit Partners: Summit Partners is a global growth equity investor focused on technology, healthcare, and financial services with comparable late-stage investing activity to Goldman Sachs Growth Equity.
- Insight Partners: Insight Partners is one of the largest dedicated technology growth equity firms globally, investing across stages similar to Goldman Sachs Growth Equity with comparable scale ($90B+ AUM). It is the most direct comparable in late-stage software and enterprise technology investing.
- General Atlantic: General Atlantic is a leading global growth equity firm investing across technology, financial services, and healthcare — directly mirroring Goldman Sachs Growth Equity's three-vertical strategy with comparable check sizes and stage focus.
- Warburg Pincus: Warburg Pincus is a pioneer of growth equity investing with global reach across technology, financial services, and healthcare — directly overlapping with Goldman Sachs Growth Equity's vertical strategy and check sizes.
- TA Associates: TA Associates is a leading global growth equity firm focused on technology, financial services, and healthcare — directly comparable to GS Growth in stage focus, sector mix, and growth-stage technology thesis.
- ICONIQ Capital: ICONIQ Capital is a growth equity and investment firm with strong ties to the enterprise software ecosystem, frequently co-investing alongside GS Growth in companies like Rippling and similar late-stage SaaS leaders.
- TPG Growth: TPG Growth is the growth equity arm of TPG, deploying capital into technology and growth-stage companies globally. It competes head-to-head with GS Growth on enterprise software, fintech, and healthcare technology deals of similar size.
- Sequoia Capital (Growth Fund): Sequoia's later-stage growth funds directly compete with Goldman Sachs Growth Equity for category-leading enterprise technology investments, often co-investing (e.g., in Grow Therapy) on rounds of comparable size.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Goldman Sachs Growth Equity social profiles
Digital presenceGoldman Sachs Growth Equity financial estimates
Financial estimateRevenue estimate
Valuation estimate
Goldman Sachs Growth Equity leadership team
Management profileNumber of profiles
Profiles3 records
Goldman Sachs Growth Equity funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Goldman Sachs Growth Equity M&A and investment
M&A and investmentM&A
Investments168 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Goldman Sachs Growth Equity
What does Goldman Sachs Growth Equity do?
Goldman Sachs Growth Equity is the growth equity investment platform within Goldman Sachs Asset Management that invests preferred equity and mezzanine capital in high-growth technology companies across Enterprise Tech, FinTech, and HealthTech. The platform complements its capital with strategic advisory through the Goldman Sachs Value Accelerator and provides portfolio companies access to Goldman Sachs' broader network and resources.
Is Goldman Sachs Growth Equity a public or private company?
Goldman Sachs Growth Equity is a private company. It is classified as public and is currently operating.
When was Goldman Sachs Growth Equity founded?
Goldman Sachs Growth Equity was founded in 2005. It employs 11 to 50 people.
Where is Goldman Sachs Growth Equity based?
Goldman Sachs Growth Equity is headquartered in New York, United States, in the North America region.
How does Goldman Sachs Growth Equity make money?
One revenue line is on record: growth Equity Investment Management.
Who are Goldman Sachs Growth Equity's main competitors?
Broad incumbents on record are Thoma Bravo and Hellman & Friedman. Direct peers are Summit Partners, Insight Partners, General Atlantic, Warburg Pincus, TA Associates, ICONIQ Capital, TPG Growth and Sequoia Capital (Growth Fund).
Does Goldman Sachs Growth Equity have an API?
No public API is recorded for Goldman Sachs Growth Equity.
What industry is Goldman Sachs Growth Equity in?
Goldman Sachs Growth Equity's product category is Growth Equity Investing. Its primary akta.pro industry code is FSANACAA, Technology & Software Growth Equity, with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 52394 and its SIC code is 6282.